Your browser doesn't support javascript.
loading
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.
Swartz, Michael D; DeSantis, Stacia M; Yaseen, Ashraf; Brito, Frances A; Valerio-Shewmaker, Melissa A; Messiah, Sarah E; Leon-Novelo, Luis G; Kohl, Harold W; Pinzon-Gomez, Cesar L; Hao, Tianyao; Zhang, Shiming; Talebi, Yashar; Yoo, Joy; Ross, Jessica R; Gonzalez, Michael O; Wu, Leqing; Kelder, Steven H; Silberman, Mark; Tuzo, Samantha; Pont, Stephen J; Shuford, Jennifer A; Lakey, David; Boerwinkle, Eric.
Afiliación
  • Swartz MD; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • DeSantis SM; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Yaseen A; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Brito FA; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Valerio-Shewmaker MA; The University of Texas Health Science Center in Houston, School of Public Health in Brownsville, Brownsville, Texas, USA.
  • Messiah SE; The University of Texas Health Science Center in Houston, School of Public Health in Dallas, Dallas, Texas, USA.
  • Leon-Novelo LG; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Kohl HW; The University of Texas Health Science Center in Houston, School of Public Health in Austin, Austin, Texas, USA.
  • Pinzon-Gomez CL; The University of Texas at Austin, College of Education, Department of Kinesiology and Health Education, Austin, Texas, USA.
  • Hao T; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Zhang S; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Talebi Y; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Yoo J; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Ross JR; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Gonzalez MO; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Wu L; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Kelder SH; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Silberman M; The University of Texas Health Science Center in Houston, School of Public Health in Austin, Austin, Texas, USA.
  • Tuzo S; Clinical Pathology Laboratories, Austin, Texas, USA.
  • Pont SJ; Clinical Pathology Laboratories, Austin, Texas, USA.
  • Shuford JA; Texas Department of State Health Services, Austin, Texas, USA.
  • Lakey D; Texas Department of State Health Services, Austin, Texas, USA.
  • Boerwinkle E; University of Texas System, Office of Health Affairs, Austin, Texas, USA.
J Infect Dis ; 227(2): 193-201, 2023 01 11.
Article en En | MEDLINE | ID: mdl-35514141

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos